Submit your Abstract! 📖🖍⏳ until 15 January 2020, no more than 1500 characters, to the Biocomputation symposium at E-MRS 2020, May 25-29, Strasbourg, France. ⚠️Please Share on your Network 📢🌐 Symposium Sponsor Bio4Comp Project H2020 Video Abstract for EMRS Submission EMRS Page The symposium will broadly cover alternative computation technologies
5,000 EURO awaiting for a winning scientist! click here: http://bio4comp.org/award.html Please share widely into the scientific and academic world! Dear scientists, friends of
Earlier this year, Dr Dan Nicolau Jr won one of the ARC Future Fellowships 2018, a prestigious Australian award. Dan extended his work with the Queensland University of Technology QUT in Brisbane, which is an Associate Member of Bio4Comp EU funded Research Project, under the H2020 Workframe (http://bio4comp.org/) The award,
Bio4Comp the new EU Research Project we are involved in, as presented by LABIOTECH.eu Better than Quantum Computing: The EU Launches a Biocomputer Project
Biomolecular machines exploring nano-fabricated networks is the core research of Bio4Comp Project on the very futuristic field of Biocomputers. Molecular Sense is further involved in this new Project, which continues the succesful work carried under Abacus Project. Bio4Comp has received funding from the European Union’s Horizon 2020 research and nnovation programme under
TTI/Vanguard is the advanced technology conference series for senior-level executives. TTI/Vanguard’s member organizations represent global private, public, and academic sectors. TTI/Vanguard introduce, discuss, and evaluate emerging and breakthrough technologies on the two-to-five-year horizon. Through conferences, workshops, and field trips, experts offer perspectives on future technologies and their impact on organizations, infrastructures,
Our research result on biocomputation is presented in the prestigious American publication Smithsonian Magazine, May 2016 edition.
Molecular Sense Ltd. based in England, which is a research-intensive company founded by two scientists Dan and Dan Nicolau, father and son, develops technologies, both soft and hard in the emerging areas of intelligent processing of biological information. Creating new methodologies for molecular surfaces – relevant to drug discovery, and